Tenderwize
Back to tender search

Pharmaceutical discount contracts from 01.05.2025 for various active substances within the framework of an Open-House procedure

AOK NordWest - Die Gesundheitskasse·Dortmund, Germany·Deadline Feb 22, 2027 · 187 days left·Open·Supplies
Original notice title

Germany – Pharmaceutical products – Arzneimittel-Rabattverträge ab 01.05.2025 zu diversen Wirkstoffen im Rahmen eines Open-House-Verfahrens

50/100

Opportunity Score

Needs reviewLow complexity
SuppliesOpen
Why this score?

Opportunity

50 / 100

Complexity

20 / 100

Risk factors

The buyer may award exclusive discount contracts during the term, causing the Open-House contracts to be suspended. The...

No contract value or volume is published; potential revenue is unknown.

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Supplies contract
  • 1 lot
  • Duration until Apr 2027
  • Supply of pharmaceutical products for the listed active substances
  • Conclusion of discount agreements under §130a Abs. 8 SGB V
Show full summary

Open-House procedure for pharmaceutical discount contracts (Rabattverträge) under §130a Abs. 8 SGB V for six active substances, offered by AOK NordWest. The procedure is not a public procurement under EU law; any eligible pharmaceutical entrepreneur may join at any time. Contracts run for max 24 months starting 01.05.2025. No estimated value disclosed. Non-exclusive, but the buyer may later award exclusive contracts that suspend these agreements.

Risks

The buyer may award exclusive discount contracts during the term, causing the Open-House contracts to be suspended. The...

No contract value or volume is published; potential revenue is unknown.

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Must be a pharmaceutical entrepreneur (pharmazeutischer Unternehmer) as defined in §4 Abs. 18 AMG for the offered medicinal products

Eligibility

  • Eligibility must persist for the entire contract duration

Administrative

  • Uniform contract terms apply; no individual negotiations

Buyer

Location

Dortmund, DEU

Website

www.aok.de

Identifier

DE124159739

Activity

Health

Lots (1)

LOT-0001

Pharmaceutical discount contracts from 01.05.2025 for various active substances within the framework of an Open-House procedure

Uniform terms for all interested pharmaceutical entrepreneurs covering active substances: Aclidiniumbromide & Formoterol (R03AL05), Carglumic acid (A16AA05), Dabigatran (B01AE07), Mepolizumab (R03DX09), Opipramol (N06AA05), Pegfilgrastim (L03AA13). Earliest start 01.05.2025, duration max 24 months.

SuppliesEU fundedElectronic submission

Location

Hagen, Germany

Duration

Apr 2025 - Apr 2027

Category

Pharmaceutical products

Deadline

Deadline Feb 22, 2027

Procurement Details

Publication date
03 Mar 2025
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
141923-2025

Documents (1)

Similar tenders